Estrella Immunopharma
Emeryville
About Estrella Immunopharma
Estrella Biopharma is a biotech firm that is dedicated to advancing cancer treatment with CD19-Redirected ARTEMIS T Cells, aiming to enhance patient outcomes. Leveraging recent breakthroughs in cell therapy, the company focuses on developing transformative medicines not only for hematological malignancies but also for solid tumors. Estrella Biopharma stands at the forefront of pioneering next-generation T-cell therapies, addressing treatment challenges across a spectrum of cancers.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $21.4M
- Funding stage: IPO
- Last round: Post-IPO Equity (Jan 2026)
- Ticker: nasdaq:ESLA
- Website: estrellabio.com
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/estrella-immunopharma-103492 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.